nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of secondary mtDNA mutations in families with Leber’s hereditary optic neuropathy: Four novel variants and their association with clinical presentation
|
Jancic, Jasna |
|
|
50 |
C |
p. 132-138 |
artikel |
2 |
A novel mutation in the mitochondrial MT-ND5 gene in a family with MELAS. The relevance of genetic analysis on targeted tissues
|
Panadés-de Oliveira, Luísa |
|
|
50 |
C |
p. 14-18 |
artikel |
3 |
Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS)
|
Nukui, Takamasa |
|
|
50 |
C |
p. 145-148 |
artikel |
4 |
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer
|
Allen, Sonia A. |
|
|
50 |
C |
p. 19-24 |
artikel |
5 |
Disturbance of mitochondrial functions associated with permeability transition pore opening induced by cis-5-tetradecenoic and myristic acids in liver of adolescent rats
|
Cecatto, Cristiane |
|
|
50 |
C |
p. 1-13 |
artikel |
6 |
Editorial Board
|
|
|
|
50 |
C |
p. ii |
artikel |
7 |
Emerging concepts of mitochondrial dysfunction in Parkinson’s disease progression: Pathogenic and therapeutic implications
|
Rani, Linchi |
|
|
50 |
C |
p. 25-34 |
artikel |
8 |
Endoplasmic reticulum stress induced apoptosis and caspase activation is mediated through mitochondria during megakaryocyte differentiation
|
Kovuru, Narasaiah |
|
|
50 |
C |
p. 115-120 |
artikel |
9 |
Extracellular matrix/mitochondria pathway: A novel potential target for sarcopenia
|
Melouane, Aicha |
|
|
50 |
C |
p. 63-70 |
artikel |
10 |
Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy
|
Poulsen, Nanna Scharff |
|
|
50 |
C |
p. 35-41 |
artikel |
11 |
Hydrogen sulfide attenuates hyperhomocysteinemia-induced mitochondrial dysfunctions in brain
|
Kumar, Mohit |
|
|
50 |
C |
p. 158-169 |
artikel |
12 |
In silico simulation of reversible and irreversible swelling of mitochondria: The role of membrane rigidity
|
Makarov, Vladimir I. |
|
|
50 |
C |
p. 71-81 |
artikel |
13 |
Ironing the mitochondria: Relevance to its dynamics
|
Upadhyay, Mamta |
|
|
50 |
C |
p. 82-87 |
artikel |
14 |
Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism
|
Ramkumar, Balaji |
|
|
50 |
C |
p. 42-50 |
artikel |
15 |
Mitochondrial complex IV is lost in neurons in the cuprizone mouse model
|
Varhaug, Kristin N. |
|
|
50 |
C |
p. 58-62 |
artikel |
16 |
Mitochondrial function and brain Metabolic Score (BMS) in ischemic Stroke: Evaluation of “neuroprotectants” safety and efficacy
|
Mayevsky, Avraham |
|
|
50 |
C |
p. 170-194 |
artikel |
17 |
Modular biogenesis of mitochondrial respiratory complexes
|
Barros, Mario H. |
|
|
50 |
C |
p. 94-114 |
artikel |
18 |
Non-invasive versus ex vivo measurement of mitochondrial function in an endotoxemia model in rat: Toward monitoring of mitochondrial therapy
|
Wefers Bettink, Mark A. |
|
|
50 |
C |
p. 149-157 |
artikel |
19 |
Sensitivity of mitochondrial DNA heteroplasmy detection using Next Generation Sequencing
|
González, María del Mar |
|
|
50 |
C |
p. 88-93 |
artikel |
20 |
The basic machineries for mitochondrial protein quality control
|
Vazquez-Calvo, Carmela |
|
|
50 |
C |
p. 121-131 |
artikel |
21 |
The changing landscape of clinical trials for mitochondrial diseases: 2011 to present
|
Khayat, Delia |
|
|
50 |
C |
p. 51-57 |
artikel |
22 |
Three rare pathogenic mtDNA substitutions in LHON patients with low heteroplasmy
|
Krylova, Tatiana D. |
|
|
50 |
C |
p. 139-144 |
artikel |